Rosiglitazone (Avandia) and Macular Edema

Overview

Journal CMAJ

Date 2006 Feb 10

PMID 16467508

Citations 10

Authors

Claire Kendall

Eric Wooltorton

Affiliations

Soon will be listed here.

Citing Articles

Agonist-controlled competition of RAR and VDR nuclear receptors for heterodimerization with RXR is manifested in their DNA binding.

Reho B, Fadel L, Brazda P, Benziane A, Hegedus E, Sen P J Biol Chem. 2023; 299(2):102896.

PMID: 36639026 PMC: 9943875. DOI: 10.1016/j.jbc.2023.102896.

The forgotten type 2 diabetes mellitus medicine: rosiglitazone.

Xu B, Xing A, Li S Diabetol Int. 2022; 13(1):49-65.

PMID: 35059243 PMC: 8733070. DOI: 10.1007/s13340-021-00519-0.

Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trials.

Qazi H J Res Med Sci. 2013; 17(12):1180-7.

PMID: 23853638 PMC: 3703172.

Drug-induced macular edema.

Makri O, Georgalas I, Georgakopoulos C Drugs. 2013; 73(8):789-802.

PMID: 23640687 DOI: 10.1007/s40265-013-0055-x.

Thiazolidinediones: a 2010 perspective.

Krishnaswami A, Ravi-Kumar S, Lewis J Perm J. 2010; 14(3):64-72.

PMID: 20844707 PMC: 2937848. DOI: 10.7812/TPP/09-052.

References

Wooltorton E . Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure. CMAJ. 2002; 166(2):219. PMC: 99278. View

Colucciello M . Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus. Arch Ophthalmol. 2005; 123(9):1273-5. DOI: 10.1001/archopht.123.9.1273. View

Cheng A . Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction. Can J Diabetes. 2013; 37 Suppl 1:S1-3. DOI: 10.1016/j.jcjd.2013.01.009. View